People
Christopher Holler
Christopher Holler was publicly named by Arkuda Therapeutics as Principal Scientist. He helped develop assays for progranulin expression and function in the FTD-GRN discovery programme. Arkuda affiliation is historical; continued employment or board membership after the2025 asset sale is unverified.
Roles
Arkuda Therapeutics
CurrentPrincipal Scientist (archived company roster; historical, current status unverified)